Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000

Sergieva S B, Timcheva K V, Hadjiolov N D

Abstract excerpt

PURPOSE: To evaluate the clinical application of (99m) Tc-methoxyisobutylisonitrile (MIBI) scintigraphy as a functional method for assessment of multidrug resistance (MDR) in breast cancer patients and the correlation of these results with P-glycoprotein (P-gp) overexpression and objective response to chemotherapy. PATIENTS AND METHODS: 22 women, 35-68 years old with breast cancer, suitable for neoadjuvant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Lobular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Epirubicin

Share to Methotrexate

Share to Neoadjuvant Therapy

Share to Radiopharmaceuticals

Share to Tomography, Emission-Computed, Single-Photon

Source

Identifiers

PMID: 17318954

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.PMID 17318954Read ↗

Dynamic imaging: scintimammography.Semantic proximity Read ↗

Imaging of multidrug resistance in cancer.Semantic proximity Read ↗

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.Semantic proximity Read ↗

Clinical imaging of multidrug resistance in cancer.Semantic proximity Read ↗

The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.Semantic proximity Read ↗

TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?Semantic proximity Read ↗

Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.Semantic proximity Read ↗

99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.Semantic proximity Read ↗

PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In VivoSemantic proximity Read ↗

Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma.Semantic proximity Read ↗

Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.